| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0079 | 1 |